Rodriguez Raul R's Form 4 filing
Rigel Pharmaceuticals Inc (RIGL) · filed Sep 3, 2026
- Accession no.
- 0000905148-26-004078
- Filed
- Sep 3, 2026, 6:59 PM ET
- Trade date
- Sep 1, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rodriguez Raul RCIK 0001190279 | Director, Officer (CEO, President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | FTax withholdingDisposed | −2,424 | $47.50 | −$115,140 | 273,362 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.